Trend Analysis on Strikeforce Technologies Inc, Dewmar International BMC Inc, RXi Pharmaceuticals Corp, Vantage Health, Advanced Cell Technology

New York, NY -- (SBWIRE) -- 02/20/2013 -- Strikeforce Technologies Inc (OTC:SFOR) closed at 0.0028. The total number of shares changed hands during the day was 9.85 million. After opening at $0.003, the stock hit as high as $0.0038. However, it traded between $0.0016 and$0.019 over the last twelve months. StrikeForce Technologies, Inc., a software development and services company, provides a suite of integrated computer network security products using proprietary technology.

Is SFOR a Solid Investment at These Levels? Read This Report For Details

Dewmar International BMC Inc (OTC:DEWM) closed yesterday at $0.0140, a -23.08% decrease. Around 9.25 million shares were traded, beating an-average trading volume of 4.12 million shares. The company is now valued at around $1.07 million. Dewmar International BMC, Inc., through its subsidiary DSD Network of America, Inc., engages in the manufacture and sale of Lean Slow Motion Potion brand relaxation beverage primarily in the Untied States. The company is based in Clinton, Mississippi.

Will DEWM Bounce Back After yesterday’s Sharp Sell off? Find Out Here

RXi Pharmaceuticals Corp (OTC:RXII) moved 44.51 per cent higher at $0.200 and traded between $0.14 and $0.20 after opening the day at $0.14. Its performance over the last five days remained 102.02%, which stands at 153.16% for a month. Going back further than one month, 1-year performance after recent close was 53.85%.RXi Pharmaceuticals Corporation discovers, develops, and commercializes therapies based on its RNAi platform. It provides RXI-109, a self-delivering RNAi compound (sd-rxRNA) for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin.

Will RXII Continue To Move Higher? Find Out Here

Vantage Health (OTC:VNTH) shares decline, decreasing -30.00 per cent to close at $0.0021. The stock is down around -62.5% this year and -94% for the last 12 months. Around 3.84 million shares changed hands yesterday, higher from an-average trading volume of 61,926 shares. Vantage Health, Inc., through its subsidiary, Moxisign (PTY) Ltd., intends to build and operate an active pharmaceutical ingredients manufacturing plant alongside a formulation and packaging plant in South Africa to meet the market needs for antiretrovirals in South Africa and other African countries for the treatment of HIV/AIDS. The company was founded in April 2010 and is based in Los Angeles, California.

Will VNTH Reach The Bottom After Yesterday’s Correction? Find Out Here

The share price of Advanced Cell Technology, Inc. (OTC:ACTC) after ranging between $0.08 and $0.08 ended 1.72% higher to settle at $0.0770.During the past 52 weeks, the stock has ranged from a high of $0.12 to a low of $0.05.So far this year, shares have gained 38.24% and 1-year performance was around -31.25%.Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic, induced pluripotency, and adult stem cell technology in the field of regenerative medicine.

For How Long ACTC will Fight for Profitability? Read This Trend Analysis report

About Alpha Penny Stocks
Alphapennystocks.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. We strive to live up to our name, Alpha, being the leader in the industry. It is important to understand that these stocks also carry high risk. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.

We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.